Skip to main content
Publications
Nance RM, Vannappagari V, Smith K, Johannes CB, Calingaert B, Saltus CW, Mayer KH, Whitney BM, Rodriguez B, Moore RD, Eron JJ, Geng E, Mathews WC, Mugavero MJ, Saag MS, Kitahata MM, Delaney JAC, Crane HM. Virologic failure among people living with HIV initiating dolutegravir-based versus other recommended regimens in real-world clinical care settings. J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):572-7. doi: 10.1097/QAI.0000000000002075
Manzano-Salgado CB, Granum B, Lopez-Espinosa MJ, Ballester F, Iniguez C, Gascon M, Martinez D, Guxens M, Basterretxea M, Zabaleta C, Schettgen T, Sunyer J, Vrijheid M, Casas M. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study. Int J Hyg Environ Health. 2019 Jul;222(6):945-54. doi: 10.1016/j.ijheh.2019.06.005
Mease P, Gladman D, Davenport E, Zhou X, Guerette B, Teng L, Kaura S, Nash P. Improvements in work productivity with up to 104 weeks of apremilast monotherapy: results from a phase 3b, randomized, controlled study in biologic-naïve subjects with active psoriatic arthritis. Poster presented at the 37th Scandinavian Congress of Rheumatology; September 5, 2018. Helsinki, Finland. [abstract] Scand J Rheumatol. 2018 Sep 5; 47(Suppl 129):34-5. Previously presented at the 2017 ACR/ARHP Annual Meeting.
Heritier H, Vienneau D, Foraster M, Eze IC, Schaffner E, Thiesse L, Ruzdik F, Habermacher M, Kopfli M, Pieren R, Schmidt-Trucksass A, Brink M, Cajochen C, Wunderli JM, Probst-Hensch N, Roosli M. Diurnal variability of transportation noise exposure and cardiovascular mortality: a nationwide cohort study from Switzerland. Int J Hyg Environ Health. 2018 Apr;221(3):556-63. doi: 10.1016/j.ijheh.2018.02.005
Vert C, Sanchez-Benavides G, Martinez D, Gotsens X, Gramunt N, Cirach M, Molinuevo JL, Sunyer J, Nieuwenhuijsen MJ, Crous-Bou M, Gascon M. Effect of long-term exposure to air pollution on anxiety and depression in adults: a cross-sectional study. Int J Hyg Environ Health. 2017 Aug;220(6):1074-80. doi: 10.1016/j.ijheh.2017.06.009
MacDougall JE, Johnston JM, Lavins BJ, Nelson LM, Williams VS, Carson RT, Shiff SJ, Shi K, Kurtz CB, Baird MJ, Currie MG, Lembo AJ. An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials. Neurogastroenterol Motil. 2013 Jun;25(6):481-6. doi: 10.1111/nmo.12089